In contrast, low-risk malignancies lacking CLDN1 expression exhibited only basal levels of FGF-2 (Figure 13), indicating a functional connection between FGF signaling and CLDN1 expression in GIST. This evidence concerns the gene FGF2 and gastrointestinal stromal tumor.